Funder
National Natural Science Foundation of China
Sichuan University
West China Hospital, Sichuan University
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference54 articles.
1. BET inhibitors: a novel epigenetic approach;Doroshow;Ann. Oncol.,2017
2. Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors;Wang;Eur. J. Med. Chem.,2020
3. Kinase and BET inhibitors together clamp inhibition of PI3K signaling and overcome resistance to therapy;Stratikopoulos;Cancer cell,2015
4. New and emerging HDAC inhibitors for cancer treatment;West;J. Clin. Invest.,2014
5. Plk1 inhibition enhances the efficacy of BET epigenetic reader blockade in castration-resistant prostate cancer;Mao;Mol. Cancer Ther.,2018
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献